
Neuland Laboratories Q2 Results 2025 Highlights: Net Profit Surged by 194.90% & Revenue Up 65.44% YoY
Posted by : sachet | Tue Nov 11 2025

Click and Sign Up to Get Live Updates on Q2 Results
Neuland Laboratories Q2 Results FY26: During Q2 FY26, Neuland Laboratories’ profit increased 194.90% YoY, while revenue increased by 65.44% YoY. The company posted robust numbers, with Q2 PAT at ₹96.85 crores and revenue at ₹514.27 crores. Neuland Laboratories showed its Q2 results on 7th November 2025.
Neuland Laboratories Q2 Results FY26: Extracts of FY25 & FY26
| Particulars | Consolidated Figures | Standalone Figures | ||
| 30th Sep 2025 | 30 Sept 2024 | 30th Sept 2025 | 30th Sept 2024 | |
| Revenue from Operations | ₹514.27 | ₹310.84 | ₹514.27 | ₹310.84 |
| Profit Before Tax (PBT) | ₹157.35 | ₹66.56 | ₹156.92 | ₹65.67 |
| Profit After Tax (PAT) | ₹96.85 | ₹32.84 | ₹96.46 | ₹31.96 |
Neuland Laboratories Q2 Results FY26 Highlights (Q2 FY26 vs FY25)
- Neuland Laboratories clocked Q2 FY26 consolidated revenue of ₹514.27 crores vs ₹310.84 crores.
- On the profit front, Neuland Laboratories earned a consolidated PAT of ₹96.85 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹32.84 crore.
- According to the consolidated figures, Neuland Laboratories’ quarterly PAT increased by 194.90% YoY, while revenue increased by 65.44%.
- Neuland Laboratories clocked Q2 FY26 standalone revenue of ₹514.27 crores vs ₹310.84 crores.
- On the profit front, Neuland Laboratories earned a standalone PAT of ₹96.46 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹31.96 crore.
- According to the standalone figures, Neuland Laboratories’ quarterly PAT increased by 201.83% YoY, while revenue increased by 65.44%.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
Neuland Laboratories Share Price Performance
On the opening bell on 11th November 2025, Neuland Laboratories shares opened at ₹18,100.00 per share. However, the initial gains have since eroded, and Neuland Laboratories shares are currently trading at ₹17,149.00 per share, which is lower than the opening price.
Considering the long-term achievements, Neuland Laboratories shares have yielded returns of approximately 36.44% over the past 6 months, and 1-year returns stand at 24.26%. Over the maximum timeframe, Neuland Laboratories shares delivered a 20,931.40% return to investors.
What Analysts Expect Post Q2 Results?
Following Neuland Laboratories’ robust Q2 results for FY26, analysts expect its share price to rise. According to analysts, Neuland Laboratories’ share price could reach ₹18,600.30 per share in the coming year and, in a downturn, could hit ₹17,000.00 per share. However, one must ignore stock market volatility and invest in Neuland Laboratories shares after thorough research.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Recent Articles
Nestle Q2 Results FY26: Q2 PAT Falls 17.38% to ₹743.17 Crore; Revenue Up 10.57% YoY
Inspira Enterprise India IPO Details: Everything You Should Know about
Swaraj Engines Q2 Results FY26: Q2 PAT Rises 8.88% to ₹49 Crore; Revenue Up 8.62% YoY
HDB Financial Q2 Results FY26: Q2 PAT Falls 1.5% to ₹581 Crore; Revenue Up 13.42% YoY
BEL Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here
Paytm Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here
Blue Dart Gears Up for Q2 Reveal on 28th October; Check Key Expectations Here
Related Posts
Mahamaya Lifesciences IPO GMP: Day 1 IPO Live Updates
Pine Labs IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Shining Tools IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Curis Lifesciences IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Pine Labs IPO Subscription Day 3: Check Online

